Sustanon 250 mg

Structure and Composition

Oil solution for injection: 1 ml ampoule of 1 pc. in the package.
        1 ml
testosterone propionate 30 mg
testosterone phenylpropionate 60 mg
60 mg of testosterone izokaproat
testosterone decanoate 100 mg

Pharmacological action
Androgenic preparation containing testosterone esters. Testosterone is essential for normal growth and development of male sex organs and secondary sexual characteristics. In adult male is needed to maintain libido, general condition, sexual potency, a function of the prostate and seminal vesicles. In the application of Sustanon-250 there is an increase of testosterone, dihydrotestosterone, androstenedione plasma levels, as well as reducing binding globulin sex steroids. In men with primary hypogonadism noted normal levels of gonadotropins.
Testosterone propionate is characterized by rapid onset and short duration of action. Testosterone phenylpropionate and izokaproat characterized by slow onset and long duration of action. Testosterone decanoate is characterized by the slow onset and long duration of action itself.

Statement
As a substitution for the following diseases and conditions:
   - Deficiency of androgen after castration;
   - Hypopituitarism;
   - Endocrine impotence;
   - Symptoms of male menopause (decreased libido, mental and physical activity);
   - Osteoporosis caused by lack of androgens.

Dosage regimen
Adequate dose of a / m administration of 1 ml of the drug one time in 3 weeks.

Side effect
Part of the endocrine and reproductive systems: priapism and other signs of excessive sexual stimulation, and precocious puberty, an increased frequency of erections, increase penis size, premature closure of epiphyses, oligospermia and decreased ejaculate volume, sodium and water retention.

Contraindications
   - Known or suspected carcinoma of the prostate or breast cancer.

Cautions
In the event of adverse reactions of  androgen, drug treatment should be discontinued. After the disappearance of these reactions to resume low-dose treatment of the drug.
Regular monitoring of medical needs for patients with the following diseases: chronic heart failure, hypertension, renal dysfunction, epilepsy, migraine.

Overdose
In acute overdose toxicity is extremely low.
In chronic overdose may develop priapism. In this case, treatment should be stopped, and after the disappearance of the symptoms - start at lower doses.

Drug Interactions
Drug interactions drug Sustanon-250 has not been described.

Conditions and terms
The drug should be stored in a dark place at a temperature of 8 ° to 25 ° C.